Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 20 Breast Neoplasms 6 Polycystic Ovary Syndrome 4 Infertility 4 Uterine Anomalies 1 Sleep Wake Disorders 1 Salpingitis 1 Salivary Gland Neoplasms 1 Primary Ovarian Insufficiency 1 Pregnancy, Ectopic 1 Neoplasm Metastasis 1 Myofibroma 1 Metabolic Syndrome 1 Lymphoma 1 Leiomyoma 1 Infertility, Female 1 Hypogonadism 1 Hodgkin Disease 1 Fatty Liver 1 Fatigue 1 Endometritis 1 Endometriosis 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Invasive Nos 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 282 Rituximab 260 Etoposide 161 Filgrastim 155 Vincristine 145 Doxorubicin 134 Prednisone 117 Cytarabine 108 Radiotherapy 102 Peripheral Blood Stem Cell Transplantation 90 Methotrexate 90 fludarabine phosphate 87 Melphalan 78 Busulfan 71 Dexamethasone 59 Granulocyte Colony-Stimulating Factor 56 Carmustine 53 fludarabine 51 Bortezomib 46 Tacrolimus 44 Mycophenolic Acid 41 Antilymphocyte Serum 41 Ifosfamide 40 Leucovorin 39 Gemcitabine 38 Whole-Body Irradiation 36 Cyclosporine 35 Bendamustine Hydrochloride 34 sargramostim 33 Methylprednisolone 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma × Triptorelin Pamoate × Clear all

NCT01160315 2015-10-30

Erasme-POF

Erasme University Hospital

Phase 2/3 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡